2019 – a year in review

As 2019 draws to a close, we’re reflecting on a an excellent year of discovery science, UK and world firsts, new treatments for patients, and new partnerships. We’ve been visited by a real-life astronaut, celebrated significant grants from generous charities, and made progress in understanding disease pathology – setting us up for a busy 2020 … Continue reading “2019 – a year in review”

Could AI help develop personalised psychosis therapies?

A new multicentre study will investigate the link between brain inflammation and psychosis, and use artificial intelligence techniques to identify patients that might benefit most from novel treatments. The study, funded by UKRI Medical Research Council, is led by BHP founder member the University of Birmingham, and the University of Cambridge. Researchers will examine how and … Continue reading “Could AI help develop personalised psychosis therapies?”

Birmingham researcher to study diabetes in dentistry

Zehra Yonel, a Clinical Lecturer in Restorative Dentistry at our founder-member the University of Birmingham, has been awarded a three-year fellowship to research type 2 diabetes (T2D) in dentistry. The NIHR-Diabetes UK Doctoral Fellowship was awarded to Zehra by the Department of Health and Social Care, and it’s due to begin in February 2020. The … Continue reading “Birmingham researcher to study diabetes in dentistry”

Groundbreaking mouth cancer trial results published

Findings recently published in the British Journal of Cancer show that removing the neck glands of patients at the same time as removing their small cancer in the mouth significantly improves their chances of cure.   The results are thanks to the first ever nationwide study to compare two different surgical treatments for early mouth … Continue reading “Groundbreaking mouth cancer trial results published”

Improving treatment for women with PCOS – £2.4m boost for researchers

A major £2.4 million research project is underway at the University of Birmingham aimed at improving treatment for women with polycystic ovary syndrome (PCOS). PCOS affects at least 10% of women and causes irregular periods and difficulties trying to conceive. Most women with PCOS have high levels of male hormones, known as androgens, in their … Continue reading “Improving treatment for women with PCOS – £2.4m boost for researchers”